Allinaire Therapeutics, LLC — Form D/A
Allinaire Therapeutics, LLC of CLEVELAND, OH, a company, filed a Form D amendment with the SEC on 2017-12-12. The offering totals $5.0M, of which $1.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-12-12
- Form: D/A
- Accession: 0001676987-17-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $1.2M
- Remaining: $3.8M
- Investors: 7
- Date of first sale: 2016-12-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-276461
Issuer
- Name: Allinaire Therapeutics, LLC
- CIK: 0001676987
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 20600 CHAGRIN BLVD., CLEVELAND, OH, 44122
- Phone: 216-455-3216
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Baiju Shah | Director | Cleveland, OH |
| Baiju Shah | Executive Officer | Cleveland, OH |
| Ted Torphy | Director | Cleveland, OH |
| Brian Stemme | Director | Indianapolis, IN |
Other filings by this issuer (2)
More